164 related articles for article (PubMed ID: 1906711)
1. Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.
Bihoreau N; Paolantonacci P; Bardelle C; Fontaine-Aupart MP; Krishnan S; Yon J; Romet-Lemonne JL
Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):23-31. PubMed ID: 1906711
[TBL] [Abstract][Full Text] [Related]
2. Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
Krishnan S; Kolbe HV; Lepage P; Faure T; Sauerwald R; de la Salle H; Muller C; Bihoreau N; Paolantonacci P; Roitsch C
Eur J Biochem; 1991 Feb; 195(3):637-44. PubMed ID: 1900236
[TBL] [Abstract][Full Text] [Related]
3. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
[TBL] [Abstract][Full Text] [Related]
4. Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
Lind P; Larsson K; Spira J; Sydow-Bäckman M; Almstedt A; Gray E; Sandberg H
Eur J Biochem; 1995 Aug; 232(1):19-27. PubMed ID: 7556150
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.
Eaton D; Rodriguez H; Vehar GA
Biochemistry; 1986 Jan; 25(2):505-12. PubMed ID: 3082357
[TBL] [Abstract][Full Text] [Related]
7. Amino acid residues 721-729 are required for full factor VIII activity.
Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.
Mertens K; Donath MJ; van Leen RW; de Keyzer-Nellen MJ; Verbeet MP; Klaasse Bos JM; Leyte A; van Mourik JA
Br J Haematol; 1993 Sep; 85(1):133-42. PubMed ID: 8251380
[TBL] [Abstract][Full Text] [Related]
9. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of a mutant recombinant blood coagulation factor VIII (rFVIII (m)).
Oh SH; Cho SY; Jin HS; Jeong DL; Jung SG; Oh KH
Exp Mol Med; 2002 Jul; 34(3):233-8. PubMed ID: 12216115
[TBL] [Abstract][Full Text] [Related]
11. Characterization of recombinant human factor VIII.
Eaton DL; Hass PE; Riddle L; Mather J; Wiebe M; Gregory T; Vehar GA
J Biol Chem; 1987 Mar; 262(7):3285-90. PubMed ID: 3102485
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.
Eaton DL; Wood WI; Eaton D; Hass PE; Hollingshead P; Wion K; Mather J; Lawn RM; Vehar GA; Gorman C
Biochemistry; 1986 Dec; 25(26):8343-7. PubMed ID: 3030393
[TBL] [Abstract][Full Text] [Related]
13. B-Domain deleted recombinant coagulation factor VIII modified with monomethoxy polyethylene glycol.
Röstin J; Smeds AL; Akerblom E
Bioconjug Chem; 2000; 11(3):387-96. PubMed ID: 10821655
[TBL] [Abstract][Full Text] [Related]
14. A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII.
Meulien P; Faure T; Mischler F; Harrer H; Ulrich P; Bouderbala B; Dott K; Sainte Marie M; Mazurier C; Wiesel ML
Protein Eng; 1988 Oct; 2(4):301-6. PubMed ID: 3150544
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a recombinant antihaemophilia-A factor (factor VIII-delta II) by matrix-assisted laser desorption/ionization mass spectrometry.
Bihoreau N; Veillon JF; Ramon C; Scohyers JM; Schmitter JM
Rapid Commun Mass Spectrom; 1995; 9(15):1584-8. PubMed ID: 8652881
[TBL] [Abstract][Full Text] [Related]
16. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
Weinstein MJ; Chute LE
J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
[TBL] [Abstract][Full Text] [Related]
17. Subunit structure of thrombin-activated porcine factor VIII.
Lollar P; Parker CG
Biochemistry; 1989 Jan; 28(2):666-74. PubMed ID: 2496750
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of factor Va and factor VIIIa by activated platelets.
Kalafatis M; Rand MD; Jenny RJ; Ehrlich YH; Mann KG
Blood; 1993 Feb; 81(3):704-19. PubMed ID: 8427963
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
De Cristofaro R; De Filippis V
Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
[TBL] [Abstract][Full Text] [Related]
20. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
